AARD
Aardvark Therapeutics, Inc.
$1.39
-64.81%
2026-10-23
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Key Fundamentals
Forward P/E
-2.12
EPS (TTM)
$-3.22
ROE
-66.0%
Profit Margin
0.0%
Debt/Equity
0.91
Price/Book
1.48
Market Cap
$110.7M
Avg Volume (10D)
136K
Recent Breakout Signals
No recent breakout signals detected for AARD.
Recent Price Range (60 Days)
60D High
$8.12
60D Low
$1.39
Avg Volume
418K
Latest Close
$1.39
Get breakout alerts for AARD
Sign up for Breakout Scanner to receive daily notifications when AARD triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Aardvark Therapeutics, Inc. (AARD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors AARD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. AARD operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.